295 related articles for article (PubMed ID: 10843460)
1. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
Bearden DT; Rodvold KA
Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
[TBL] [Abstract][Full Text] [Related]
2. Effects of obesity on pharmacokinetics implications for drug therapy.
Cheymol G
Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial dosing in obese patients.
Wurtz R; Itokazu G; Rodvold K
Clin Infect Dis; 1997 Jul; 25(1):112-8. PubMed ID: 9243045
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of drugs in obesity. An update.
Cheymol G
Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
6. The association of elevated trough serum vancomycin concentrations with obesity.
Richardson J; Scheetz M; O'Donnell EP
J Infect Chemother; 2015 Jul; 21(7):507-11. PubMed ID: 25851852
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
8. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
[TBL] [Abstract][Full Text] [Related]
9. Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis.
Jennings DL; Makowski CT; Chambers RM; Lanfear DE
Int J Artif Organs; 2014 Mar; 37(3):270-4. PubMed ID: 24619894
[TBL] [Abstract][Full Text] [Related]
10. Effect of obesity on the pharmacokinetics of drugs in humans.
Hanley MJ; Abernethy DR; Greenblatt DJ
Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of anti-infective agents in paediatric patients.
Butler DR; Kuhn RJ; Chandler MH
Clin Pharmacokinet; 1994 May; 26(5):374-95. PubMed ID: 8055682
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of antibacterial drugs in neonates.
Paap CM; Nahata MC
Clin Pharmacokinet; 1990 Oct; 19(4):280-318. PubMed ID: 2208898
[TBL] [Abstract][Full Text] [Related]
13. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.
Henry SL; Galloway KP
Clin Pharmacokinet; 1995 Jul; 29(1):36-45. PubMed ID: 7586897
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial dosing considerations in obese adult patients.
Pai MP; Bearden DT
Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
[TBL] [Abstract][Full Text] [Related]
15. Dosage adjustment of antiinfective therapy in patients with renal impairment.
Eckhardt A; Borner K; Keller F; Zellner D
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
[TBL] [Abstract][Full Text] [Related]
16. Drug disposition in obese humans. An update.
Abernethy DR; Greenblatt DJ
Clin Pharmacokinet; 1986; 11(3):199-213. PubMed ID: 3524955
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies.
Durand C; Bylo M; Howard B; Belliveau P
Ann Pharmacother; 2018 Jun; 52(6):580-590. PubMed ID: 29262697
[TBL] [Abstract][Full Text] [Related]
18. Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.
Williams DN; Raymond JL
Clin Pharmacokinet; 1998 Jul; 35(1):65-77. PubMed ID: 9673835
[TBL] [Abstract][Full Text] [Related]
19. Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.
Grace E
J Antimicrob Chemother; 2012 Jun; 67(6):1305-10. PubMed ID: 22382471
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.
Morrill HJ; Caffrey AR; Noh E; LaPlante KL
Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
